The rapamycin-derivative RAD001 (everolimus) inhibits cell viability and interacts with the Akt-mTOR-p70S6K pathway in human medullary thyroid carcinoma cells.

Source:http://linkedlifedata.com/resource/pubmed/id/19815051

Mol. Cell. Endocrinol. 2010 Feb 5 315 1-2 87-94

Download in:

View as

Triples

General Info

PMID
19815051